An elevated level of copper zinc superoxide dismutase fails to prevent oxygen induced retinopathy in mice

British Journal of Ophthalmology

Volumn 80, Issue 5, 1996, Pages 429-434

  Klaeger, Corina ^a   De Sa, Luis ^c   Klaeger, Andres J ^a   Carlson, Elaine J ^b   Good, William V ^a,b,d   Epstein, Charles J ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c University Hospital   (Brazil)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; INDIAN INK; OXYGEN; OXYGEN RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA; RETINOPATHY; TRANSGENIC MOUSE;

EID: 0029996854     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.80.5.429     Document Type: Article

References (44)

1. Patz A, Hoeck KE, DeLa Cruz E. Studies on the effect of high oxygen administration in retrolental fibroplasia. I. Nursery observations. Am J Ophthalmol 1952; 35: 1248-53.
2. Kinsey VE. Retrolental fibroplasia. Cooperative study of retrolental fibroplasia and the use of oxygen. Am J Ophthalmol 1956; 56: 481-543.
3. 2 levels and retrolental fibroplasia: a report of the cooperative study. Pediatrics 1977; 60: 655-68.
4. Flynn JT. Acute proliferative retrolental fibroplasia: multivariate risk analysis. Trans Am Ophthalmol Soc 1983; 81: 549-91.
5. Majima A. Studies on retinopathy of prematurity 1. Statistical analysis of factors related to occurrence and progression in active phase. Jpn J Ophthalmol 1977; 21: 404-20.
6. Sacks LM, Schaffer DB, Anday EK, Peckham GJ, Delivoria-Papadopoulos M. Retrolental fibroplasia and blood transfusion in very low-birth-weight infants. Pediatrics 1981; 68: 770-4.
7. Bossi E, Koerner F, Zulauf M. Retinopathy of prematurity: risk factors - a statistical analysis of matched pairs. Retinopathy Prematurity Conference 1981; 2: 536-9.
8. Silverman WA. Retinopathy of prematurity: oxygen dogma challenged. Arch Dis Child 1982; 57: 731-3.
9. Bancalari E, Flynn JT, Goldberg RN, Bawol R, Cassady J, Schiffman J. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics 1987; 79: 663-9.
10. Flynn JT, Bancalari E, Snyder ES, Goldberg RN, Feuer W, Cassady J. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med 1992; 326: 1050-4.
11. Phelps DL, Vitamin E and retrolental fibroplasia in 1982. Pediatrics 1982; 70: 420-5.
12. Muller DPR. Vitamin E therapy in retinopathy of prematurity. Eye 1992; 6: 221-5.
13. Gaton DD, Gold J, Axer-Siegel R, Wielunsky E, Naor N, Nissenkorn I. Evaluation of bilirubin as possible protective factor in the prevention of retinopathy of prematurity. Br J Ophthalmol 1991; 75: 532-4.
14. Epstein CJ, Avraham KB, Lovett M, Smith E, Elroy-Stein O, Rotman G, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA 1987; 84: 8044-8.
15. Connolly SE, Hores TA, Smith LE, D'Amore PA. Characterization of vascular development in the mouse retina. Microvasc Res 1988; 36: 275-90.
16. Penn JS, Thum LA, Naash MI. Oxygen-induced retinopathy in the rat. Vitamin C and E as potential therapies. Invest Ophthalmol Vis Sci 1992; 33: 1836-45.
17. Ashton N. Some aspects of the comparative pathology of oxygen toxicity in the retina. Br J Ophthalmol 1968; 52: 505-31.
18. Heyman E, Ohlsson A, Girschek P. Retinopathy of prematurity and bilirubin. N Engl J Med 1989; 320: 256.
19. Boynton BR, Boynton CA. Retinopathy of prematurity and bilirubin. N Engl J Med 1989; 321: 193-4.
20. Fauchère J-C, Meier-Gibbons FE, Koerner F, Bossi E. Retinopathy of prematurity and bilirubin - no clinical evidence for a beneficial role of bilirubin as a physiological antioxidant. Eur J Pediatr 1994; 153: 358-62.
21. Yamashita H, Horie K, Yamamoto T, Katagiri H, Asano T, Hirano T. Superoxide dismutase in developing mouse retina. Jpn J Ophthalmol 1994; 38: 148-61.
22. Chan PH, Yang GY, Chen SF, Carlson E, Epstein CJ. Cold-induced brain edema and infarction are reduced in transgenic mice overexpressing CuZn-superoxide dismutase. Ann Neurol 1991; 29: 482-6.
23. Kinouchi H, Epstein CJ, Mizui T, Carlson E, Chen SF, Chan PH. Attenuation of focal cerebral ischemic injury in transgenic mice overexpressing CuZn superoxide dismutase. Proc Natl Acad Sci USA 1991; 88: 11158-62.
24. Przedborski S, Kostic V, Jackson-Lewis V, Naini AB, Simonetti S, Fahn S, et al. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J Neurosci 1992; 12: 1658-67.
25. Cadet JL, Sheng P, Ali S, Rothman R, Carlson E, Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J Neurochem 1994; 62: 380-3.
26. Kinouchi H, Epstein CJ, Carlson EJ, Noble LJ, Gafni J, Chan PH. Superoxide dismutase dependent attenuation of blood brain barrier disruption and edema following contusive brain injury. Proc XVIth Symposium on Cerebral Edema and Metabolism May 22-28, 1993; Sendaui, Japan.
27. Kubisch HM, Wang J, Luche R, Carlson E, Bray TM, Epstein CJ, et al. Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. Proc Natl Acad Sci USA 1994; 91: 9956-9.
28. Sakashita A, Epstein CJ, Carlson E, Koeffler HP. Hematopoietic progenitor cells of transgenic mice with increased copper/zinc-superoxide dismutase activity are resistant to tumor necrosis factor. J Cell Physiol 1994; 160: 233-8.
29. White CW, Avraham KB, Shanley PF, Groner Y. Transgenic mice with expression of elevated levels of copper-zinc superoxide dismutase in the lungs are resistant to pulmonary oxygen toxicity. J Clin Invest 1991; 87: 2162-8.
30. Feeney L, Berman ER. Oxygen toxicity: membrane damage by free radicals. Invest Ophthalmol 1976; 15: 789-92.
31. Ditelberg J, Sheldon RA, Epstein CJ, Ferriero DM. Brain injury after perinatal hypoxia-ischemia is exacerbated in copper/zinc superoxide dismutase transgenic mice. J Invest Med 1995; 43: 141A.
32. Smith LEH, Freedman SF, Foley ED, McLellan A, Schwartz P. The effect of overexpression of Cu/Zn superoxide dismutase on oxygen-induced retinopathy in a transgenic mouse. Invest Ophthalmol Vis Sci 1994; 45 (suppl): 1442.
33. Scott MD, Meshnick SR, Eaton JW. Superoxide dismutase-rich bacteria. Paradoxical increase in oxidant toxicity. J Biol Chem 1987; 262: 3640-5.
34. Gyllensten LJ, Hellstrom BE. Experimental approach to the pathogenesis of retrolental fibroplasia. I. Changes to the eye induced by exposure of newborn mice to concentrated oxygen. Acta Paediatr Scand 1954; 43 (suppl 100): 131-48.
35. Henry MM, Tolman BL, Penn JS. Exposure to alternating hypoxia and hyperoxia causes severe proliferative retinopathy in the newborn rat. Invest Ophthalmol Vis Sci 1993; 34 (suppl): 837.
36. Reynaud X, Dorey CK. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Invest Ophthalmol Vis Sci 1994; 35: 3169-77.
37. Flynn JT. Retinopathy of prematurity. Pediatr Clin North Am 1987; 34: 1487-516.
38. Kremer I, Kissun R, Nissenkorn I, Ben-Sira I, Garner A. Oxygen-induced retinopathy in newborn kittens. A model for ischemic vasoproliferative retinopathy. Invest Ophthalmol Vis Sci 1987; 28: 126-30.
39. Patz A, Eastham A, Higgenbotham DH, Kleh T. Oxygen studies in retrolental fibroplasia. II. The production of the microscopic changes of retrolental fibroplasia in experimental animals. Am J Ophthalmol 1953; 36: 1511-22.
40. Michaelson IC, Herz N, Lewkowitz E, Kertesz D. Effect of increased oxygen on the development of the retinal vessels. Br J Ophthalmol 1954; 38: 577-87.
41. Gerschman R, Nadig PW, Snell AC, Nye SW. Effect of high oxygen concentrations on eyes of newborn mice. Am J Physiol 1954; 179: 115-8.
42. Gole GA, Browning J, Elts SM. The mouse of oxygen-induced retinopathy: a suitable animal model for angiogenesis research. Doc Ophthalmol 1990; 74: 163-9.
43. Smith LEH, Wesolowski E, McLellan A, Sullivan R, D'Amore PA. Development of a quantifiable reproducible murine model of oxygen induced proliferative retinopathy. Invest Ophthalmol Vis Sci 1993; 34 (suppl): 1448.
44. Smith LEH, Wesolowski E, McLellan A, Kostyk SD, D'Amato R, Sullivan R, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994; 35: 101-11.